Certificate of Advanced Studies in Lung cancer - second cohort (CASLu2)
24.03.2021 - 26.05.2022
APPLICATION CLOSED
POSTGRADUATE PROGRAMME
Block 6
15.01.2022 - 15.04.2022
CASLu2: Module 4: Principles of treatment of SCLC, MPM, thymoma and thymic cancer
Programme
15 January | ||
| SCLC: Pathology, staging and prognostic factors for SCLC Antonio Calles, ES | ||
| SCLC: Management of very early disease with local treatment Alexandros Papachristofilou, CH | ||
| SCLC: Multi-modality treatment of LD SCLC Dirk De Ruysscher, NL | ||
| Treatment of ED SCLC Martin Früh, CH | ||
| MPM: Pathology, staging and prognostic factors Paul Baas, NL | ||
| MPM: Multimodality treatment with curative intent Olivia Lauk, CH | ||
| MPM: Systemic treatment of unresectable disease Alessandra Curioni-Fontecedro, CH | ||
| Thymoma & thymic cancer: Pathology, staging and prognostic factors Alexandar Tzankov, CH | ||
| Thymoma & thymic cancer: Surgery and multimodality concepts Stefano Cafarotti, CH | ||
| Thymoma & thymic cancer: Systemic treatment Nicolas Girard, FR | ||
| Rare thoracic cancer: Trachea Daniel Franzen, CH | ||
| Rare thoracic cancer: Neuroendocrine tumours - pathology Aurel Perren, CH | ||
| Rare thoracic cancer: Neuroendocrine tumours - therapeutic management Antonio Calles, ES | ||
| Oligo-metastatic lung disease: Surgical resection Stefano Cafarotti, CH | ||
| Oligo-metastatic lung disease: SBRT Dirk De Ruysscher, NL | ||
| Supportive therapy to systemic therapy Markus Jörger, CH | ||
| Palliative therapy: pain Caroline Hertler, CH | ||
| Palliative therapy: dysponea Daniel Franzen, CH | ||
| Treatment of CNS metastases Nicolaus Andratschke, CH | ||
| Psycho-social interventions Luzia Travado, PT | ||
| Guidelines ESMO, NCCN, ASCO Antonio Passaro, IT | ||
Faculty
Nicolaus Andratschke, University of Zurich Hospital, Department of Radiation Oncology, Zurich, CH
Paul Baas, The Netherlands Cancer Institute, Department of Thoracic Oncology, Amsterdam, NL
Stefano Cafarotti, EOC - Ospedale Regionale Bellinzona e Valli, Thoracic Surgery Dpt., Bellinzona, CH
Alessandra Curioni-Fontecedro, Gattikon, CH
Dirk De Ruysscher, University Hospital Maastricht, Dept. of Radiotherapy, Maastricht, NL
Daniel Franzen, University of Zurich Hospital, Dept. of Pulmonology, Zurich, CH
Martin Früh, St. Gallen Cantonal Hospital, Dept. of Internal Medicine, St. Gallen, CH
Nicolas Girard, Institut Curie, ., Paris, FR
Markus Jörger, St. Gallen Cancer Centre, Dept of Medical Oncology and Clinical Pharmacology, St.Gallen, CH
Olivia Lauk, University of Zurich Hospital, Dept. of Thoracic Surgery, Zurich, CH
Alexandros Papachristofilou, University Hospital Basel, Radiation Oncology Dpt., Basel, CH
Aurel Perren, University of Bern, Institute of Pathology, Bern, CH
Luzia Travado, Champalimaud Foundation, Champalimaud Centre For the Unknown, Lisbon, PT
Alexandar Tzankov, Basel University Hospital, Institute of Pathology, Basel, CH